Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$42.67 USD
+0.03 (0.07%)
Updated Jul 22, 2024 04:00 PM ET
Pre-Market: $42.72 +0.05 (0.12%) 9:06 AM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (71 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.67 | 1.35 | 9.99 |
Current Quarter Estimate | 1.64 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 1.75 | 0.12 | 54.84 |
Next Quarter Estimate | 1.64 | 7.81 | 63.00 |
Next Year Estimate | 7.04 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -92.68 | 15.20 | 15.67 |
Next Year | 1,180.00 | 10.40 | 9.31 |
Last 5 Years | 13.90 | 1.00 | 8.10 |
Next 5 Years | 5.00 | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 40.61 | -2.18 |
Price/Book (MRQ) | 5.22 | 2.16 |
Price/Cash Flow (MRFY) | 3.42 | 16.71 |
Dividend Yield | 5.63% | 0.00% |
Net Profit Margin (TTM) | -13.50% | -100.57% |
Return on Equity (TTM) | 8.83% | -49.27% |
Debt to Equity (MRQ) | NA | 0.13 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.